NEW YORK--(BUSINESS WIRE)--Smart Vision Labs, the maker of a smartphone-based autorefractor, announces the release of new data on its SVOne autorefractor being published in a leading peer-reviewed ...
SALT LAKE CITY, February 11, 2026--iVeena Delivery Systems, Inc. ("iVeena"), a clinical-stage ophthalmology company developing novel pharmacologic therapies for refractive eye diseases, today ...
Raleigh, NC - February 04, 2026 - PRESSADVANTAGE - Porter Ophthalmology announced the release of a comprehensive new ...
A new treatment vertical in eye care, pharmacologic agents for refractive correction, is in the early stage of ...
Omaha, Neb.-based Kugler Vision’s Lance Kugler, MD, joined the AcuFocus IC-8 intraocular lens clinical study. 1. Designed for patients with cataracts, the IC-8 intraocular lens is a clear, mono-focal ...
These strategic promotions reflect iVeena's commitment to scaling its organizational capabilities and accelerating development of its lead asset, IVMED-85, a first-in-class investigational eye drop ...
Please provide your email address to receive an email when new articles are posted on . Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and ...
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results